ExodusPoint Capital Management, LP
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in BBOT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$430,691
New position
Shares Held
48,122
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 67 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. BBOT ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
178,779 | $33,798,169 | |
| 2 | INSM |
INSMED Inc
|
148,133 | $24,222,708 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
227,084 | $17,051,737 | |
| 4 | ABVX |
Abivax S.A.
|
140,262 | $15,618,173 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
372,175 | $14,325,015 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
317,351 | $12,767,030 | |
| 7 | BHVN |
Biohaven Ltd.
|
1,501,099 | $12,699,297 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
173,425 | $10,084,663 |
All Filings in BBOT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $430,691 | 48,122 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||